WallStreetZenWallStreetZen

NASDAQ: FDMT
4d Molecular Therapeutics Inc Stock Ownership - Who owns 4d Molecular Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have 4d Molecular Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Scott BizilyCLO2026-10-161,635$12.84
$20.99kSell
Scott BizilyCLO2026-10-161,635$4.14
$6.77kBuy
David KirnCEO;Pres2026-10-0558,061$12.92
$750.21kSell
David KirnCEO;Pres2026-10-05272$13.61
$3.70kSell
Scott BizilyCLO2026-09-161,635$4.14
$6.77kBuy
Scott BizilyCLO2026-09-161,635$13.65
$22.32kSell
David KirnCEO;Pres2026-09-1458,333$13.90
$811.00kSell
Scott BizilyCLO2026-09-01584$14.00
$8.18kSell
Scott BizilyCLO2026-09-01584$6.49
$3.79kBuy
David KirnCEO;Pres2026-08-1925,927$16.42
$425.64kSell

1 of 4

FDMT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FDMT insiders and whales buy or sell their stock.

FDMT Shareholders

What type of owners hold 4d Molecular Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP8.26%4,563,211$50.33MInsider
Viking Global Investors LP7.69%4,247,914$46.85MInsider
David Kirn2.37%1,309,153$14.44MInsider
Tony Dung Ling Yao1.93%1,063,744$11.73MInsider
David Schaffer1.63%901,215$9.94MInsider
John F. Milligan0.18%100,000$1.10MInsider
Bvf Partners L P0.16%87,911$969.66kInsider
Ashoo Gupta0.09%47,055$519.02kInsider
Charles Theuer0.08%41,684$459.77kInsider
August J. Moretti0.02%11,045$121.83kInsider

1 of 3

FDMT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FDMT0.11%22.42%Net SellingNet Selling
LXRX0.03%99.97%Net Buying
SLDB0.11%61.44%Net SellingNet Selling
DSGN0.07%65.02%
AURA0.09%4.39%Net Selling
View Top Biotech Stocks

4d Molecular Therapeutics Stock Ownership FAQ

Who owns 4d Molecular Therapeutics?

4d Molecular Therapeutics (NASDAQ: FDMT) is owned by 0.11% institutional shareholders, 22.42% 4d Molecular Therapeutics insiders, and 77.47% retail investors. Ra Capital Management LP is the largest individual 4d Molecular Therapeutics shareholder, owning 4.56M shares representing 8.26% of the company. Ra Capital Management LP's 4d Molecular Therapeutics shares are currently valued at $54.58M.

If you're new to stock investing, here's how to buy 4d Molecular Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.